Access Only Access1 Access2 Access3 August 25, 2022 Pralsetinib: Targeted Therapies for RET-Fusion Positive NSCLC
Cancer Ear, Nose & Throat (ENT) August 22, 2022 Nasopharyngeal Cancer: A Disease More Prevalent Among Asians
Cancer Ear, Nose & Throat (ENT) August 15, 2022 Southeast Asia: Highest Mortality Rate for Tongue Cancer
Cancer August 12, 2022 Doctor On Call (DOC): Dr Steven Tucker – Cancer Screening & Prevention – Making It Personal (Part 2)
Cancer August 9, 2022 Doctor On Call (DOC): Dr Steven Tucker – Cancer Screening & Prevention – Making It Personal (Part 1)
Access1 Access2 Access3 Cancer Medication & Drugs Respiratory July 27, 2022 Tepotinib (Tepmetko) for METex14-altered NSCLC
Access1 Access2 Access3 Cancer Medication & Drugs July 14, 2022 Immune Checkpoint Inhibitors in Oncology: Pembrolizumab (Keytruda)
Access1 Access2 Access3 Cancer Medication & Drugs June 16, 2022 Immune Checkpoint Inhibitors in Oncology: Nivolumab (Opdivo)
Access1 Access2 Access3 Cancer Medication & Drugs May 19, 2022 HSA Approves First-In-Class Sacituzumab Govitecan (Trodelvy) for Metastatic Triple Negative Breast Cancer (mTNBC)